Command Palette

Search for a command to run...

Clinical Trials · NCT03347890

Reward Mechanisms in Obesity

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Zoltan Pataky
Enrollment
70
Start date
Mar 2018
Locations
1 site, Switzerland
Primary endpoint
Change of Bold Oxygenation Level Dependent (BOLD) signal (%) in brain regions involved in the reward system
View Liraglutide compound reference